Kineret anakinra: Phase II/III data; Under review in the U.S., Canada, Europe and Australia

Additional data from AMGN's 472-patient Phase II trial of Kineret showed that 75 mg and 150 mg doses of the

Read the full 201 word article

How to gain access

Continue reading with a
two-week free trial.